← Back to Search

Geriatric Assessment for Cancer Survivorship

N/A

Recruiting

Led By Haifaa Abdulhaq, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 65 years and above

Diagnosis of cancer and completion of chemotherapy with curative intent

Must not have

Nursing home resident

Advanced dementia or serious cognitive impairment that would impede ability to participate in the interview

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4-6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether giving an older cancer survivor a care plan and follow-up visit improves their quality of life.

Who is the study for?

This trial is for adults aged 65 or older who have finished chemotherapy with the goal of curing cancer. They must be scheduled to receive a survivorship care plan from an oncology navigator and able to participate in interviews. It's not for those with advanced dementia, serious cognitive issues, or nursing home residents.

What is being tested?

The study is testing if adding a geriatric assessment visit after giving older adults a survivorship care plan can improve their quality of life and satisfaction with care post-chemotherapy compared to just receiving the care plan alone.

What are the potential side effects?

Since this trial involves assessments rather than medications, there are no direct side effects like you'd expect from drugs. However, participants may experience emotional or psychological impacts when discussing their health and experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older.

Select...

I have cancer and finished chemotherapy aimed at curing it.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I live in a nursing home.

Select...

I do not have advanced dementia or serious cognitive issues that would prevent me from participating in an interview.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4-6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4-6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of the study: survey

Study retention rate

Secondary study objectives

Health related quality of life assessment by QLQ14

Health related quality of life assessment by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire EORTC QLQ-30

Patient satisfaction assessment by PSCC (Patient Satisfaction with Cancer related Care) tool

+1 more